Inhibition of the MAPK activation pathway in Amela tumor lines led to reduced Smad3 signaling, affected expression of EMT hallmark genes and inhibited proinflammatory cytokine Ccl2 gene expression and production by the melanoma cells. Here, SMAD3 is linked to melanoma.